US 11033550
Medicament
granted A61KA61K31/519A61P
Quick answer
US patent 11033550 (Medicament) held by Takeda Pharmaceutical Company Limited expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jun 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K31/519, A61P, A61P11/00, A61P9/12